Can We Deal with Learning Curves in Acute Stroke?

When an interventional cardiology center, where interventional cardiology specialists work alongside neurologists and radiologists, start a thrombectomy program in acute stroke, results achieved are similar to those at an interventional neurology center.

¿Podemos afrontar la curva de aprendizaje en el stroke agudo?

Mechanical thrombectomy has proven to be the best treatment option for acute ischemic stroke. However, it is not widely available, mainly due to logistic difficulties.

An endovascular treatment program for acute stroke was initiated in 2012 at a cardiac cath lab.

The decision to perform the procedure was taken by neurologists based on symptoms and tomographic findings. The primary endpoint was functional result (Modified Rankin Scale score) of patients 3 months after the procedure.

From the beginning of the program in 2012 until the end of enrollment in 2019, 333 patients were treated.

Clinical results did not change significantly during this period of time and almost half the population achieved a modified Rankin Scale score of 0-2 (47.9%).

Symptomatic intracerebral hemorrhage was observed in 5.7% of patients, while embolization of new vascular territory was informed in 1.8%.


Read also: Experts Reach Consensus on Post TAVR Pacemaker Indication.


The clinical results were as desired from the beginning of the program without the effect of a learning curve.

These data support the potential for interventional cardiologists to treat acute stroke in regions where therapy is not available due to a lack of interventional neurologists.

Conclusion

An interventional cardiology center with experienced staff working as a team with neurologists and radiologists can begin an endovascular treatment program for acute stroke with results comparable to those of a center with interventional neurologists. These results can be obtained from the start without a learning curve.

Original Title: Stable Clinical Outcomes When a Stroke Thrombectomy Program Is Started in an Experienced Cardiology Cath Lab.

Reference: Jakub Sulženko et al. JACC Cardiovasc Interv. 2021 Apr 12;14(7):785-792. doi: 10.1016/j.jcin.2021.01.025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...